Danish pharmaceutical multinational Leo Pharma has appointed Sarah Kleinpeter as its UK and Ireland vice president.
Kleinpeter joins the company from GlaxoSmithKline where she was previously general manager for Finland operations.
She has a strong record of launching specialty pharmaceuticals across the G7 countries, including several biologic treatments, Leo Pharma has said.
Kleinpeter succeeds the outgoing VP and managing director Geraldine Murphy, who was in charge of UK and Ireland operations for over eight years.
Kleinpeter commented: “I am excited to join LEO Pharma, and share many of the same values as the business, most notably, putting patients first. The opportunity to address the unmet needs of dermatology patients is something we can achieve through our strong pipeline, matched with our company culture and people.”
“My priorities will be understanding patient and external stakeholder needs and challenges to inform our thinking, and to strengthen our ability to be pioneers in the dermatology space.
“I am a firm believer in being externally focused, whilst also fostering a strong internal culture where employees can flourish. We have the potential and ambition to be the preferred dermatology care partner, improving people’s lives around the world, and I believe we have an exciting future ahead.”